Bioqual, Inc. engages in the provision and development of medical research and consulting services to commercial clients and government laboratories. The company is headquartered in Rockville, Maryland. The company also performs in vitro contract research services. The company is involved in the evaluation of vaccines, vaccine therapeutics, microbicides, and drug therapies. Its services also encompass sample processing and custom assays for serology, cell-mediated immunity, viral loads, and bacterial enumeration. Its additional services include advanced biocontainment (BSL3), imaging services, animal model development, and IND-enabling services. Its lab services include cell-based assays, immunoassays, toxicity and cytotoxicity testing, viral load testing, and tailored assay development.
BIOQ stock price ended at $32.5 on 星期三, after rising 0.00%
On the latest trading day Jul 01, 2026, the stock price of BIOQ rose by 0.00%, climbing from $32.50 to $32.50. During the session, the stock saw a volatility of 0.00%, with prices oscillating between a daily low of $32.50 and a high of $32.50. Notably, trading volume dropped by -- shares on the last day despite the price increase, which may signal a potential uptick in risk in the near term. A total of 1.2K shares were traded, equating to a market value of approximately $28.9M.